Clinical Trials Directory

Trials / Completed

CompletedNCT06674824

Role of Spectrophotometer in Early Prediction of Weaning Induced Cardiac Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Weaning induced cardiac dysfunction is a common cause of weaning failure in critically ill patients. plethysmography variability index (PVI) is a non-invasive, real-time, and automated parameter for evalu¬ating fluid responsiveness. By proving the validity of (PVI) in predicting successful spontaneous breathing trial Massimo can be used an easy noninvasive method that help in deciding the right time for weaning.

Conditions

Interventions

TypeNameDescription
DEVICEmassimomeasure plethysmography variability index in patients on spontaneous trial planning for extubation and evaluate its sensitivity in relation to transthoracic echocardiographic velocity time integral in early detecting weaning induced pulmonary edema

Timeline

Start date
2024-10-25
Primary completion
2025-03-18
Completion
2025-04-28
First posted
2024-11-05
Last updated
2025-08-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06674824. Inclusion in this directory is not an endorsement.

Role of Spectrophotometer in Early Prediction of Weaning Induced Cardiac Dysfunction (NCT06674824) · Clinical Trials Directory